Andros Pharmaceuticals Co.,Ltd

Andros Pharmaceuticals Co.,Ltd is a biopharmaceutical company that develops novel drug delivery platform technologies. Its pipeline includes APC101, a fast-drying, film-forming, meter-dosed spray in Phase IIa trials for pain associated with post-herpetic neuralgia; APC201, a novel topical anesthetic dosage form in Phase I/II trials for osteoarthritis; and siRNA, an anti-sense oligonucleotide and DNA candidate. Preclinical products include APC310 and APC501 for anesthesia in intravenous catheter placement and venipuncture, and APC401, a special emulsified solution for post-surgery pain. The company also offers LALP cream for dermal analgesic applications, iMinos solution for Alopecia Androgenetica, and T4 endonuclease V. Founded in 2008, Andros Pharmaceuticals Co.,Ltd is based in Zhubei, Taiwan.